You have 9 free searches left this month | for more free features.

City

Barcelona (1)

Boston (1)

Chicago (1)

Malaga (1)

Orange (1)

San Sebastian (1)

Santander (1)

Santiago De Compostela (1)

Zaragoza (1)

Condition

Cancer (1)

Diffuse Intrinsic Pontine Glioma (1)

Diffuse Midline Glioma, H3 K27M-Mutant (1)

Pancreatic Ductal Adenocarcinoma (1)

Overall Status

Recruiting (2)

Available (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Agenus Inc. (1)

Ann & Robert H Lurie Children's Hospital of Chicago (1)

Nelum Corp (1)

Collaborator

Agenus Inc. (1)

Apices Soluciones S.L. (1)

Children's Hospital of Orange County (1)

Dana-Farber Cancer Institute (1)

University of Calgary (1)

Intervention

zalifrelimab (3)

balstilimab (2)

gemcitabine (1)

nab paclitaxel (1)

nlm-001 (1)

rhsc-dipgvax (1)

Study Documents

Intervention Type

drug (3)

biological (1)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (2)

Expanded Access (1)

zalifrelimab

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cancer Trial (Balstilimab, Zalifrelimab)

Available

Cancer

Balstilimab
Zalifrelimab

(no location specified)

Oct 5, 2022

Pancreatic Ductal Adenocarcinoma Trial in Spain (Gemcitabine, Nab paclitaxel, NLM-001)

Recruiting

Pancreatic Ductal Adenocarcinoma

Gemcitabine
+3 more

Santiago De Compostela, A Coruña, Spain
+5 more

Dec 5, 2022

Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Orange, Chicago, Boston (rHSC-DIPGVax,

Recruiting

Diffuse Intrinsic Pontine Glioma
Diffuse Midline Glioma, H3 K27M-Mutant

rHSC-DIPGVax
+2 more

Orange, California
+2 more

Nov 10, 2022